G Medical Innovations Holdings Ltd
OTC:GMVDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 5-Year Average (16.5), the stock would be worth $-0 (541% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.8 | $0 |
0%
|
| 5-Year Average | 16.5 | $-0 |
-541%
|
| Country Average | 3.4 | $-0 |
-189%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| KY |
G
|
G Medical Innovations Holdings Ltd
OTC:GMVDF
|
26k USD | -3.8 | -0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 0.4 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 0.4 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.5 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 1.4 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.9 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 12.3 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 1.4 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 3.4 |
| 70th Percentile | 7.1 |
| Max | 403 |
Other Multiples
G Medical Innovations Holdings Ltd
Glance View
G Medical Innovations Holdings Ltd. engages in the development of mobile and e-health solutions and monitoring service platforms. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The company is developing the mobile technologies and services that are designed to allow consumers, patients and providers to monitor, manage and improve clinical and personal health outcomes. Its products consist of Prizma medical device (Prizma), a clinical grade device that can transform any smartphone into a medical monitoring device; Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (ECG) data including QT Syndrome Prolongation Detection Capabilities Patch. The company is also developing Wireless Vital Signs Monitoring System (VSMS), which will provide real time monitoring of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (IDTF) monitoring services and private monitoring services.
